chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial flu like symptoms first 2 days. Third day a chest pain came that progressively got worse and never went away. By the 6th day I went to the ER. Was diagnosed with Costochondritis that night.  Was sent to ER again by my doctor following an appointment a month later due to stomach issues. I was sent to the ER again via ambulance after getting blurry vision, slurred speech, loss of movement and nearly fainting August 19, 2021. I was then hospitalized august 20, 2021. I had extremely severe chest pain that night and I ended up experiencing whatever that was. The ER and hospital was unsure of what happened. Ambulance advised me that my pulse dropped and electrolytes were low. I have lost nearly 40 pounds since the shot due to loss of appetite. I have been given prednisone off and on, NSAIDs, oxycodone after my last ER visit and am currently taking gabapentin. I am now starting pain management and physical therapy.
When they got home after injections, their son c/o large amount of pain in right arm and shoulder. Approx. 11 Am. No redness or edema noted per parents. Unusual behavior, crying and screaming out in pain for several hours after injection per parents. Parents denied difficulty in breathing, skin color was good, no seizure activity. Parents wanted to know what they should do because their son's behavior was not normal. Discussed taking their son to ED. Parents decided that they would  monitor their son at home. Discussed giving their son a OTC pain reliever, cool compresses to the site and encourage movement of arm. If behavior continues to take their son to their doctor or ED. Parents had wrapped their son's arm with coban wrap and this nurse advised to take wrap off of arm immediately.  Parents thought compression wrap would be the best for treatment, this nurse advised them not to wrap arm up with coban. Spoke with parents at 1:30 and their son was still c/o of pain, parents had not given OTC pain reliever at this time. Encouraged parents to give OTC pain reliever and encourage movement of arm. Parents stated that site was not red or swollen. Spoke with parents by phone at 3:30 pm and their son was feeling better now, OTC pain reliever was given at 2:30 pm. Phone call to parents on 8/24/17- their sons pain was better and he was in school.
12  hours of vaccine spot swelling (all of shoulder), 48 hours of intense/constant headache, and general muscle aches/malaise, with periodic chills, and nausea.
Morning after injection, pt noted itching and small reddened area at injection site. On 8/16/12 red firm area noted at injection site approx. 1 1/2" x 2" and warm pink area on arm measuring 2" wide x 7" long. (Site if (R) arm- upper subcutaneous- site of varicella vaccination). Provider suspects erythema nodosum vs cellulitis. Treated with Amoxicillin 500 mg tid.
injured her foot; trouble walking; This is a spontaneous report from a contactable consumer (patient) received from a Pfizer sponsored Program Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient injured her foot and she had trouble walking on an unspecified date. She was scheduled tomorrow for the second dose on 16Apr2021 and she could not stand on the line. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old male patient received BNT162b2 (BNT162B2), on 11Jul2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 37 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient received Paxlovid treatment from 09Jan2023 to 15Jan2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
accumulated a lot of mucus in throat-hard to swallow-unproductive cough-upper lt arm painful/swollen, tingling-going to forearm & then lt leg;lt leg went numb from thigh to toes;numb on lt side of face;
8min after injection, felt dry mouth; BP was checked, SBP was 160s, HR 110s.  Felt a little dizzy.  Felt some palpitations.  BP went down soon thereafter to 140s, but HR still 100s (above baseline).; BP was checked, SBP was 160s, HR 110s.  Felt a little dizzy.  Felt some palpitations.  BP went down soon thereafter to 140s, but HR still 100s (above baseline).; BP was checked, SBP was 160s, HR 110s.  Felt a little dizzy.  Felt some palpitations.  BP went down soon thereafter to 140s, but HR still 100s (above baseline).; BP was checked, SBP was 160s, HR 110s.  Felt a little dizzy.  Felt some palpitations.  BP went down soon thereafter to 140s, but HR still 100s (above baseline).; This is a spontaneous report from a non-contactable Physician (Patient). A 36-year-old male Patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020 at 12:45 PM at single dose (vaccine location was Left arm) via unknown route of administration for unknown indication. Medical history included Psoriasis and concomitant medications were not reported. There were no allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. 8min after injection on 18Dec2020, Patient felt dry mouth, BP was checked, SBP was 160s, Heart rate (HR) 110s. He Felt a little dizzy and some palpitations. BP went down soon thereafter to 140s, but HR still 100s (above baseline). Patient received Benadryl 25mg IV as treatment. Patient did have covid prior vaccination and did not have covid tested post vaccination. Patient went to Emergency Room Visit. The outcome of the events was recovered on 18Dec2020.  No follow-up attempts are possible. Information about lot/batch number could not be requested.
pt recv vax & temp elevated to 104 ax times 36hr that started about 6PM that evening w/extreme fussiness;MD notified by parents;pt given APAP alternated w/Ibuprofen q 4hr while awake;
flu; Initial information was received on 10-Dec-2020 regarding an unsolicited valid non-serious case from a consumer or non-health care professional (patient) via social media.   This case involves a patient (age and gender unspecified) who experienced flu (influenza), while the patient received INFLUENZA VACCINE.  The patient's past vaccination(s) included flu shot (INFLUENZA VACCINE) for prophylactic vaccination. It was reported as patient had with gotten flu shot for years.  Medical history, medical treatment, family history and concomitant medication/therapy were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number, expiry date and other doing details not reported] for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported as the patient had the flu one year and thought it going to up shuck his/her guts out.   Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for event.  There will be no information available on the batch number for this case.
Pt received Quadracel (DTaP/IPV) and Proquad (MMR/Varivax) today. She appeared fine after the vaccines but in the waiting room at the checkout desk she had a brief episode of syncope and became poorly responsive; She was brought back to an exam room, assessed  and seemed better. She was given some candy to eat. Her responsiveness improved and she was quietly sitting in her mother?s lap; Dr came in to examine her and once again her responsiveness diminished and she appeared to have a brief episode of syncope; Dr placed her on the exam table with her feet elevated; She continued for several more minutes to be hyporesponsive; She never had seizure activity and did not lose consciousness; Her O2 saturation was continuously monitored by finger and did not decrease below the mid-90?s. HR remained in the 80?s to 90?s. On my exam her heart rhythm was steady. No irregularity. Pulses were normal in upper and lower extremities; She remained in a prone position and became increasingly more responsive. We offered her water which she drank and monitored her in the office for at least 45 more minutes; She had completely returned to her normal behavior and responsiveness at the time we let her go home. She was upright, walking around and interacting normally; Discussed with mother that the sequence of events was most consistent with a hypotensive hyporesponsive episode (HHE) associated with the pertussis vaccine she received today. There is no long-term sequelae.
Shoulder pain; Trouble sleeping due to the pain; This spontaneous case was received on 22-Dec-2020 from other non-health professional (consumer) via Agency (reference number: SEQW20-05912) and concerned a 19-year-old, female patient.   The patient had no relevant medical history and was not taking any concomitant medications.   On 28-Oct-2020, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine; dose: 0.5 ml, route of administration: intramuscular and anatomical location: not reported) for influenza prophylaxis. The batch number reported was P100267084.  On 30-Oct-2020, 48 hours after receiving Afluria Quadrivalent, the patient felt shoulder pain and had trouble sleeping due to the pain.   On an unspecified date in 2020, the patient visited physician's office. She had no improvement on shoulder.  At the time of initial reporting on 22-Dec-2020, the patient had not recovered from events.  The reporter did not provide a causality assessment.  This case was assessed as non-serious.   This case is linked to case 202008399 (due to same reporter).  Company comment:The patient developed arthralgia and sleep disorder two days after vaccination with the suspect product, Afluria Quadrivalent. Chronology is plausible. The patient had no relevant medical history and was not taking any concomitant medications. Considering all above mentioned, causal relationship for arthralgia is assessed as possibly related (defaults to ''related'' in the safety database for reporting purposes). Causality for sleep disorder is assessed as not related, since the event developed due to pain.; Sender's Comments: The patient developed arthralgia and sleep disorder two days after vaccination with the suspect product, Afluria Quadrivalent. Chronology is plausible. The patient had no relevant medical history and was not taking any concomitant medications. Considering all above mentioned, causal relationship for arthralgia is assessed as possibly related (defaults to ''related'' in the safety database for reporting purposes). Causality for sleep disorder is assessed as not related, since the event developed due to pain.
Pt received shot then reported a feeling of her throat closing or getting tight within 5-10 minutes. Pharmacist determined epinephrine should be administered and gave her an Epi-Pen dose. EMS was called she was evaluated and allowed to leave on her own after recovering.
This case was reported by a physician via sales rep and described the occurrence of fever in a male patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever. On an unknown date, the outcome of the fever was unknown. It was unknown if the reporter considered the fever to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported.
Within 10 minutes of receiving the vaccine I developed an odd metallic taste in my mouth along with a dull headache.  It is now seven hours since being vaccinated the metallic taste has persisted even after eating and drinking.
Patient had swelling of left knee per MD, notified by MD to put warm compress for swelling.
mother of child reports child had fever up to 102, left arm swelling and passed out. 4/11- the evening after receiving immunization advised medical evaluation. Follow up mother reports fever gone, arm still swollen.
Patient reports 2 days after 2nd dose, lost vision in lower quadrant of left eye. Went to general practitioner that sent him to an eye specialist. MD confirmed no health condition that would have prompted loss of vision. Patient informed them of COVID vaccination and MD stated couldn't rule out possibility of relation. Patient confirms that loss of vision has not resolved and is an ongoing issue.
Approximately 5 days after vaccine administered ( January 12) started itching sporadically.  On Thursday, January 21, 2021 noticed a red rash on arm under the injection site about 4 inches in length.  Arm also was sore and felt warm to the touch. Took some Ibuprofen and Claritin. Today, January 23 the rash is a light pink and slightly itches.
I received the Pfizer COVID-19 vaccination, and experience injection site soreness. My nursing toddler (22month old) experienced the following adverse side effects: loose stool (days 2-4 post vaccine), vomiting (72hrs post vaccine), 102 -103 degree fever for several days/nights (beginning 72hrs post vaccine), wet cough (beginning 24-48hrs post vaccine, and ongoing), extreme congestion (immediately after first nursing session post vaccine and ongoing), exhaustion (72hrs post vaccine and ongoing), sensitivity to lights/brightness (24hrs post vaccine and ongoing), and irritability (beginning 24hrs posts vaccine and ongoing).
First - severe nausea, then numbness in throat, face, arms and hands.  Weakness in arms and hands, dizziness, confusion.
Pt received shingrix vaccine mid July through pharmacy.  Within two weeks, she experienced shortness of breath and vesicular rash on her face.  She had been able to walk 3 miles a day and now unable to walk across the room without SOB.  Pt had not had an asthma flare up in 40 years.  Using allergist as her PCP, allergiest  and diabetic resource.  Pt came two  Urgent Care after having difficulties for almost two months. She was hypoxic 88% and sent to hospital, admitted and a few days later having CABG
Rash developed at injection site within first 24hrs.  Rash was circular, dark pink, and itchy.  Rash size peaked approximately one week after injection and then receded to until pinkness only remains at injection site and is no longer itchy.  At 36 days following injection, a hard lump and pinkness remains at the injection site.  No treatment was taken for rash.
Patient received the vaccine and within thiry seconds described shortness of breath and chest tightness - took one puff of her Albuterol inhaler and stated she took one bendaryl before coming to facility then immediately had an anxiety attack.
Initial misuse report received from a healthcare professional on 21 November 2013 and on 21 March 2014. A '5-year-old' patient (No information was provided regarding the patient) had received a 0.25 ml dose of FLUZONE instead of 0.5 ml i.e. underdoes. No adverse event was reported. List of documents held by sender: none.
3 1/2 hours after vaccines administered client developed hoarseness when crying.  5/31/07 afternoon hoarseness became worse. No other symptoms related.  Infant very fussy. By 6/1/07 hoarseness subsided and infant well. No treatment administered.
First dosage: sore arm  Second dosage:  Headaches, chills, body aches, nauseated, sore arm, and dizziness,
pt had 2 doses of Moderna dates of 3/13/2021 and 4/10/2021 and was accidently given a dose of Pfizer     no side effects at time of reporting
Nine days after received Moderna COVID?19 Vaccine EUA, I developed rash and tissue warmness on left arm where shot was administered. Itching passed after the first day. Tissue was still noticeably warm for at least 36 hours from onset.
Headache, body aches, left arm pain.  Painful swollen lump under left armpit.
Arm felt tingly after; This is a spontaneous report from a non-contactable nurse. A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EK5730) solution for injection intramuscular in the left arm on 20Dec2020 at 12:30 (at the age of 30-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. There was no medical history. There were no concomitant medications. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 20Dec2020 at 12:30, the patient experienced arm felt tingly after. No treatment was provided for the event arm felt tingly after. The outcome of the event arm felt tingly after was recovered in Dec2020. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Patient was pregnant at time of both her COVID 19 vaccinations. Patient delivered a boy on May 4th, 2021 at 38wks gestation. Per infants discharge, patient was noted to have a loud split S2 this am with progresstive murmur/gallop by this afternoon. pulse ox 88-90% and started on O2 via NC. Able to wean fairly quickly but failed subsequent CCHD with right hand of 98% and R foot of 89% off of O2 with tachycardia of 170s. At that time, restarted O2, CXR showed cardiomegaly and EKG showed LVH. Murmur present loudest at LUSB and moderate tachycardia and pallor. Discussed case with NICU, and decision mace to start prostaglandins 0.03mcg/kg/min adter 10mg/kg bolus of caffeine. Patient discharged to secondary NICU. Per other information, infant has a aorta development issue.
Started screaming inconsolable that night, took to er they said it was ?normal? the next day he could no longer talk or make eye contact. He is now 8 and cannot speak. Is in diapers. Can?t feed or bath himself and attends special education school.
Information has been received from a medical assistant, referring to a patient of unknown age and gender. Information about medical history, concurrent condition and concomitant therapy was unknown. On 24-APR-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (lot# M041990, expiration date: 23-JUL-2018; strength, route and frequency unknown) for prophylaxis. No adverse effects were reported. Temperature excursion was reported as below 0 Celsius degrees (-0.26 Celsius degrees) for 30 minutes. There was no previous temperature excursion. A digital data logger was involved. This is one of two cases received from the same reporter.; Sender's Comments:  US-00950713-1810USA001861:
It all started with pain in the arms of the body, head, nausea, dizziness and excessive fatigue, then it is swollen on the face throat and with hives all over the body, this had already happened after the second dose but they told me it was not caused by the vaccine so I have been taking antihistamines and receiving a vaccine since May to control allergies until now That I received the booster everything worsens again.
Felt bad initially afterward vaccine but thought that was normal. The next day, Saturday, woke up vomiting with hives felt feverish with a scratchy throat. Went to the ER on the following day on Sunday because chest hurting and shortness of breath, dizzy and felt like fainting
Swelling in arm, went to md, still swollen on 10/11/2019.
Ulceration of vulva with several ulcers surrounding larger lesion. Treated with lidocaine ointment, clobetasol topical cream and acetaminophen hydrocodone tablets PRN pain. Symptoms resolved on their own after 7 days.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A male patient received bnt162b2 (BNT162B2), administration date 31Aug2021 12:00 (Batch/Lot number: unknown) as dose 1, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPOAESTHESIA (non-serious), INJECTION SITE HYPOAESTHESIA (non-serious) all with onset 31Aug2021, outcome "unknown" and all described as "He is having numbness on the side of his face and the injection site is numb". Additional information: The caller reported that he just got his first dose of the Pfizer-BioNTech Covid-19 vaccine at 12:00 EST today. He is having numbness on the side of his face and the injection site is numb. He stated his face feels like he was at the dentist with less sensation. He stated these symptoms were pretty instant when he got the shot. He stated he is not having any issues breathing and has not gotten any worse and might be getting slightly better. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
first dose on May-2021/second dose on 14-Dec-2021/patient received 2nd dose of Moderna COVID-19 vaccine 7 months after 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on May-2021/second dose on 14-Dec-2021/patient received 2nd dose of Moderna COVID-19 vaccine 7 months after 1st dose) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination.     No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on May-2021/second dose on 14-Dec-2021/patient received 2nd dose of Moderna COVID-19 vaccine 7 months after 1st dose). On 14-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on May-2021/second dose on 14-Dec-2021/patient received 2nd dose of Moderna COVID-19 vaccine 7 months after 1st dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
Sharp nerve type pain in left arm that has moved up to left shoulder blade and into the spinal area in between my shoulder blades. The pain causes a cold ice pick feeling. It?s hard to turn my head to the left. I had arm soreness since injection with headache that lasted until yesterday late, nausea, fatigue, chills all over and achy body. These pains in my shoulder, neck and back started this morning when I woke up. I did wake up around 4am with cold sweats that actually caused me to sweat through my clothes and hair. This new pain is severe.
30min p/vax T102;pt recv vax 22SEP97;was adm on 25SEP97 & released on 27SEP97;had hx of inc temp & was dx w/pneumonia 25SEP97;
Red, firm, warm swelling around the injection site.  The area is not really painful but itchy.  I first noticed this about 52 hours ago and it has increased in size from a pin point to about a 3?x6? area.  I have no other symptoms.
Woke around 4 am with severe body aches, headache, and itching to the site, and nausea and fatigue